BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7833276)

  • 1. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
    Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
    Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Soluble lymphocyte antigens in hematological diseases].
    Yoneyama A; Higashihara M; Nakahara K
    Rinsho Ketsueki; 1995 Apr; 36(4):286-92. PubMed ID: 7783331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble CD4 and CD8 levels in Kawasaki disease.
    Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
    Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.
    Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N
    Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
    Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome.
    Sawada S; Sugai S; Iijima S; Takei M; Paredes E; Hayama T; Nishinarita S; Hosokawa Y; Horie T; Obara T
    Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
    Mansueto S; Vitale G; Mocciaro C; Gambino G; Colletti P; Mansueto P; Spinelli A; Affronti M; Chifari N; Arcoleo F; Milano S; Cillari E
    Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
    Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
    Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease.
    Balázs C; Bokk A; Farid NR
    Thyroid; 1994; 4(1):27-30. PubMed ID: 8054859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
    Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
    J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus.
    Sawada S; Hashimoto H; Iijima S; Tokano Y; Takei M; Shida M; Obara T
    J Clin Lab Anal; 1993; 7(3):141-6. PubMed ID: 8509943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
    Marcante R; Cavedon G
    Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
    Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
    Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.
    Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G
    Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.
    Vitale G; Mocciaro C; Malta R; Gambino G; Spinelli A; Giordano C; Stassi G; Arcoleo F; Milano S; Cillari E
    Clin Exp Immunol; 1994 Aug; 97(2):280-3. PubMed ID: 8050177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infectious mononucleosis].
    Yoneyama A
    Rinsho Byori; 2001 Oct; 49(10):996-9. PubMed ID: 11769479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum soluble CD2, CD4 and CD8 levels in infectious mononucleosis].
    Motohashi T
    Arerugi; 1993 Aug; 42(8):926-33. PubMed ID: 7902699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
    Xie J; Wang HL; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation.
    Ho AD; Maruyama M; Maghazachi A; Mason JR; Glück S; Corringham RE
    Blood; 1994 Nov; 84(10):3550-7. PubMed ID: 7949110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding of the soluble form of the CD8 complex by CD8+/HLA-DR+ cells in HIV-1-infected patients.
    Agostini C; Pizzolo G; Zambello R; Trentin L; Siviero F; Vinante F; Morosato L; Francavilla E; Cadrobbi P; Semenzato G
    AIDS; 1991 Jul; 5(7):813-9. PubMed ID: 1832545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.